The artificial intelligence device helps detect polyps during colonoscopies. It’s compatible with any colonoscopy video and uses advanced AI to recognize the presence of precancerous lesions with a visual marker in real time.
The FDA granted de novo clearance for the device in April.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.